These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9537431)

  • 1. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells.
    Gaetaniello L; Fiore M; de Filippo S; Pozzi N; Tamasi S; Pignata C
    Hepatology; 1998 Apr; 27(4):934-42. PubMed ID: 9537431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.
    Torimoto Y; Dang NH; Vivier E; Tanaka T; Schlossman SF; Morimoto C
    J Immunol; 1991 Oct; 147(8):2514-7. PubMed ID: 1680916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.
    Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH
    Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
    Hegen M; Camerini D; Fleischer B
    Cell Immunol; 1993 Feb; 146(2):249-60. PubMed ID: 7909722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early phosphorylation events induced by DPIV/CD26-specific inhibitors.
    Kähne T; Neubert K; Faust J; Ansorge S
    Cell Immunol; 1998 Oct; 189(1):60-6. PubMed ID: 9758695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
    Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J; Olek S; Fleischer B; von Bonin A
    Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoelectron microscopic demonstration of the membrane proteases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26 in normal and neoplastic renal parenchymal tissues and cells.
    Stange T; Kettmann U; Holzhausen HJ
    Eur J Histochem; 2000; 44(2):157-64. PubMed ID: 10968363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity.
    Steeg C; Hartwig U; Fleischer B
    Cell Immunol; 1995 Sep; 164(2):311-5. PubMed ID: 7656337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.
    Ohnuma K; Yamochi T; Uchiyama M; Nishibashi K; Iwata S; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Mol Cell Biol; 2005 Sep; 25(17):7743-57. PubMed ID: 16107720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
    Alexia C; Lasfer M; Groyer A
    Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytofluorographic evidence that thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status.
    Ruiz P; Nassiri M; Steele B; Viciana AL
    Cytometry; 1996 Apr; 23(4):322-9. PubMed ID: 8900475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
    J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgD receptor-mediated signal transduction in T cells.
    Lakshmi Tamma SM; Wu Y; Toporovsky I; Lima V; Coico RF
    Cell Immunol; 2001 Feb; 207(2):110-7. PubMed ID: 11243700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry.
    Klobusická M; Babusíková O
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():34-7. PubMed ID: 10707830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.
    Aytac U; Claret FX; Ho L; Sato K; Ohnuma K; Mills GB; Cabanillas F; Morimoto C; Dang NH
    Cancer Res; 2001 Oct; 61(19):7204-10. PubMed ID: 11585756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase.
    Hegen M; Kameoka J; Dong RP; Schlossman SF; Morimoto C
    Immunology; 1997 Feb; 90(2):257-64. PubMed ID: 9135555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
    Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
    Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.